We report on the cytogenetic findings in a family study of pyridoxine responsive, X linked sideroblastic anaemia. An increase in the number of X chromosomes was observed in a smali proportion of metaphases prepared from five female members, but these findings did not strictly correlate with the carrier status of the condition. No consistent cytogenetic abnormality could be identified vr associated with this rare familial condition. The diagnosis and counselling ofcarriers ofthis condition is discussed.
prescribed iron tablets, and blood transfusions. Since the female carriers also have an increased rate of erythropoiesis in order to compensate for the ineffective nature of half of their red cell production, they are also thought to be at risk of iron overload in later life,2 especially if iron tablets are taken unnecessarily over long periods of time.
The primary defect in congenital X linked SA is not known. Decreased delta aminolaevulinic acid synthase (ALAs) and haem synthase activities are frequent findings, but there is as yet no convincing or substantiated evidence for the primary abnormality being an abnormal or absent enzyme of haem synthesis.3 The two populations of red cells in the female carriers of this condition argue against the inheritance being via maternal mitochondria; therefore, some abnormality must reside on the X chromosome. It was hoped that cytogenetic studies on stimulated lymphocytes from the members of the family described here would show a visible X chromosome abnormality that would be informative regarding the position of the affected gene on this chromosome, would help in neonatal and prenatal diagnosis of the condition, and would help focus more detailed DNA studies. The locus for idiopathic acquired sideroblastic anaemia (IASA) is believed to be at Xql3. 4 Case report We report a study of a family with X linked sideroblastic anaemia. The proband II.5 (fig 1) presented at the age of 8 Cytogenetic findings One hundred metaphases from each member of the family except III.6, III.7, and III.9 were studied. In no case was there any abnormality found that could be linked with the sideroblastic abnormality found in the proband and the carriers. In particular, high resolution analysis showed no deletion or rearrangement at Xql3. However, there were some changes. In family member I.1 two metaphases were seen with trisomy 8, one of which also contained a deletion of Sq in the region q13-q22, features characteristically observed in the bone marrow of patients with myelodysplastic syndromes.7 No other significant chromosome rearrangements were seen in any family member. The incidence and distribution of gaps and breaks appeared consistent in all cases with that expected after induction of fragile site expression by methotrexate and thymidine synchronisation. Greater than expected X chromosome gain8 was observed in five females (I. 
